David W. Gray

5.0k total citations · 2 hit papers
69 papers, 2.9k citations indexed

About

David W. Gray is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David W. Gray has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 23 papers in Epidemiology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David W. Gray's work include Trypanosoma species research and implications (19 papers), Research on Leishmaniasis Studies (15 papers) and Biochemical and Molecular Research (9 papers). David W. Gray is often cited by papers focused on Trypanosoma species research and implications (19 papers), Research on Leishmaniasis Studies (15 papers) and Biochemical and Molecular Research (9 papers). David W. Gray collaborates with scholars based in United Kingdom, United States and Germany. David W. Gray's co-authors include Ian Marshall, Marianne LeMeur, Dominic Cosgrove, Diane Mathis, Christophe Benoist, Jim Kaufman, Andrée Dierich, Manu De Rycker, Paul G. Wyatt and Alan H. Fairlamb and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

David W. Gray

66 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mice lacking MHC class II molecules

1991 768 citations David W. Gray et al. profile →
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need

2017 306 citations Mark C. Field, Alan H. Fairlamb et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Gray United Kingdom	27	962	723	662	565	422	69	2.9k
Célia R. S. Garcia Brazil	36	934 1.0×	535 0.7×	627 0.9×	1.7k 3.0×	182 0.4×	121	3.3k
Grahame J. McKenzie United Kingdom	24	1.3k 1.3×	896 1.2×	198 0.3×	276 0.5×	471 1.1×	37	3.0k
Kelly L. Rogers Australia	33	1.5k 1.5×	890 1.2×	367 0.6×	672 1.2×	214 0.5×	84	3.4k
Michael Duszenko Germany	33	1.5k 1.5×	381 0.5×	1.4k 2.2×	963 1.7×	713 1.7×	83	3.4k
Elisabetta Bianchi Italy	33	1.9k 1.9×	426 0.6×	621 0.9×	149 0.3×	277 0.7×	83	3.8k
Clive Bate United Kingdom	33	1.3k 1.4×	570 0.8×	324 0.5×	958 1.7×	937 2.2×	96	3.3k
Keiko Kobayashi Japan	31	1.2k 1.3×	718 1.0×	220 0.3×	301 0.5×	283 0.7×	204	3.4k
Massimo Santoro Italy	37	2.0k 2.1×	544 0.8×	668 1.0×	96 0.2×	211 0.5×	106	4.0k
Yan Wu China	28	1.5k 1.6×	618 0.9×	1.0k 1.6×	105 0.2×	158 0.4×	105	3.9k
William B. Cowden Australia	39	1.2k 1.3×	2.1k 2.9×	378 0.6×	1.9k 3.4×	570 1.4×	96	5.7k

Countries citing papers authored by David W. Gray

Since Specialization

Citations

This map shows the geographic impact of David W. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Gray more than expected).

Fields of papers citing papers by David W. Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Gray. The network helps show where David W. Gray may publish in the future.

Co-authorship network of co-authors of David W. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Gray. A scholar is included among the top collaborators of David W. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Gray. David W. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lang, Stuart, Daniel A. Fletcher, Paul K. Fyfe, et al.. (2024). Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments. ChemMedChem. 19(13). e202400025–e202400025.

Lin, De, Sandra M. O’Neill, Lauren Webster, et al.. (2024). Identification of a potent and selective LAPTc inhibitor by RapidFire-Mass Spectrometry, with antichagasic activity. PLoS neglected tropical diseases. 18(2). e0011956–e0011956. 1 indexed citations

Tamaki, Fábio K., C. Bailey, David W. Gray, et al.. (2024). HTS library plate rejuvenation using a DMSO-rich atmosphere. SLAS TECHNOLOGY. 29(6). 100204–100204.

Armstrong, Lee A., Sven M. Lange, Virginia De Cesare, et al.. (2021). Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. PLoS ONE. 16(7). e0253364–e0253364. 51 indexed citations

Oh, Sangmi, M. Daben J. Libardo, Shaik Azeeza, et al.. (2021). Structure–Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular Agents. ACS Infectious Diseases. 7(2). 479–492. 13 indexed citations

Beauchamp, Erwan, Megan C. Yap, Aishwarya Iyer, et al.. (2020). Targeting N-myristoylation for therapy of B-cell lymphomas. Nature Communications. 11(1). 5348–5348. 50 indexed citations

McElroy, Stuart P., Timur R. Samatov, Andrew Woodland, et al.. (2014). Identification of Small Molecule Inhibitors of Pre-mRNA Splicing. Journal of Biological Chemistry. 289(50). 34683–34698. 62 indexed citations

Rycker, Manu De, Irene Hallyburton, John Thomas, et al.. (2013). Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay. Antimicrobial Agents and Chemotherapy. 57(7). 2913–2922. 108 indexed citations

Rycker, Manu De, et al.. (2012). A Static-Cidal Assay for Trypanosoma brucei to Aid Hit Prioritisation for Progression into Drug Discovery Programmes. PLoS neglected tropical diseases. 6(11). e1932–e1932. 30 indexed citations

10.

Gardiner, Mary, Stuart P. McElroy, Daniel James, et al.. (2012). Assessment of Pseudomonas aeruginosa N5,N10-Methylenetetrahydrofolate Dehydrogenase - Cyclohydrolase as a Potential Antibacterial Drug Target. PLoS ONE. 7(4). e35973–e35973. 18 indexed citations

11.

Miles, Katherine, et al.. (2010). Turnover and lifespan of plasma cells in models of acute and chronic disease. Immunology. 131. 135–135. 1 indexed citations

12.

Biggadike, Keith, et al.. (2007). Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(3). L660–L667. 119 indexed citations

13.

Wiethe, Robert W., et al.. (2006). Array synthesis of progesterone receptor antagonists: 3-Aryl-1,2-diazepines. Bioorganic & Medicinal Chemistry Letters. 16(14). 3777–3779. 14 indexed citations

14.

Jones, David G., Xi Liang, Eugene L. Stewart, et al.. (2005). Discovery of non-steroidal mifepristone mimetics: Pyrazoline-based PR antagonists. Bioorganic & Medicinal Chemistry Letters. 15(13). 3203–3206. 26 indexed citations

15.

Gray, David W., et al.. (1995). Muscarinic Cholinoceptor‐Stimulated Synthesis and Degradation of Inositol 1,4,5‐Trisphosphate in the Rat Cerebellar Granule Cell. Journal of Neurochemistry. 64(3). 1143–1151. 4 indexed citations

16.

Gray, David W., R. A. John Challiss, & Stefan R. Nahorski. (1994). Differential Effects of Lithium on Muscarinic Cholinoceptor‐Stimulated CMP‐Phosphatidate Accumulation in Cerebellar Granule Cells, CHO‐M3 Cells, and SH‐SY5Y Neuroblastoma Cells. Journal of Neurochemistry. 63(4). 1354–1360. 13 indexed citations

17.

Gray, David W. & Ian Marshall. (1992). Human α‐calcitonin gene‐related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. British Journal of Pharmacology. 107(3). 691–696. 127 indexed citations

18.

Gray, David W. & Ian Marshall. (1992). Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta. European Journal of Pharmacology. 212(1). 37–42. 83 indexed citations

19.

Gray, David W. & Ian Marshall. (1992). Novel signal transduction pathway mediating endothelium‐dependent β‐adrenoceptor vasorelaxation in rat thoracic aorta. British Journal of Pharmacology. 107(3). 684–690. 167 indexed citations

20.

Gray, David W., et al.. (1984). Prevention of Introduction of Foreign Objects into the Sarns Series 5000 Arterial Pumphead. Journal of ExtraCorporeal Technology. 16(3). 102–103.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact